Posted in | News | Gold

Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan

Riverside Resources and Sierra Madre Developments have obtained assay results of a comprehensive soil sampling program that was specifically designed to test the possible west expansions of the oxide gold mineralization, which was identified during the phase I drill program conducted at the El Capitan target in Penoles project.

Mineralized gold of economic grade was discovered in the El Capitan drill program over a strike of around 700 m and the mineralized zone seems to be exposed for an extension along strike towards the area’s west and northwest part.

An oxide gold prospect that is partly outlined, two former silver mines and several targets of previous phase are present in the Penoles project. Those early phase targets located in a land package, enclose over half of the former Penoles Mining district.

A near-surface overburden masks the zone mineralization at the El Capitan together with the possible extension. The company has decided to complete a comprehensive soil sampling before performing further drill testing. It gathered a total of 980 samples at the intervals of 12.5 m along 25 m of spaced profile lines for along the strike for more than 350 m of the zone mineralization. Nevada-based Inspectorate Laboratories examined the soil samples with the help of standard fire assay methods and strong anomalous values of gold are found within west-northwest striking anomaly of thickness from 150 to 250 m. This anomaly expands from the DDH 11-05 across the complete survey grid and is exposed towards the western part. Many soil samples from the southwest part of DDH 11-05 yielded strong anomalous values of gold. The company has planned to start further drill testing at El Capitan target. The results are pending.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan. AZoMining. Retrieved on November 22, 2024 from https://www.azomining.com/News.aspx?newsID=6191.

  • MLA

    Scanlon, Joel. "Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan". AZoMining. 22 November 2024. <https://www.azomining.com/News.aspx?newsID=6191>.

  • Chicago

    Scanlon, Joel. "Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan". AZoMining. https://www.azomining.com/News.aspx?newsID=6191. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan. AZoMining, viewed 22 November 2024, https://www.azomining.com/News.aspx?newsID=6191.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.